jnc12408-sup-0001-FigS1-S5.docxWord document4658K

Appendix S1.Supplementary Materials and methods.

Figure S1. 5-Nonyloxytryptamine oxalate (5-NOT) competes with colominic acid for binding to the PSA-specific antibody 735 (mAb 735).

Figure S2. Representative images of (a) cerebellar neurons, (b) hippocampal neurons, (c) motor neurons and (d) Schwann cells bearing neurites/processes.

Figure S3. Nonyloxytryptamine stimulates myelination of dorsal root ganglion neurons in vitro.

Figure S4. Nonyloxytryptamine treatment does not influence the viability of IMR-32 cells.

Figure S5. MAP2 expression is down-regulated in IMR-32 cells after 5-NOT treatment.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.